Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005829 | cytosol | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QCW3
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 2 |
GO:0006520 | amino acid metabolic process | 3 | 2 |
GO:0006553 | lysine metabolic process | 6 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008652 | amino acid biosynthetic process | 4 | 2 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0009066 | aspartate family amino acid metabolic process | 5 | 2 |
GO:0009067 | aspartate family amino acid biosynthetic process | 6 | 2 |
GO:0009085 | lysine biosynthetic process | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016053 | organic acid biosynthetic process | 4 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
GO:0019878 | lysine biosynthetic process via aminoadipic acid | 8 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0044283 | small molecule biosynthetic process | 3 | 2 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
GO:1901605 | alpha-amino acid metabolic process | 4 | 2 |
GO:1901607 | alpha-amino acid biosynthetic process | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000287 | magnesium ion binding | 5 | 7 |
GO:0003824 | catalytic activity | 1 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0008897 | holo-[acyl-carrier-protein] synthase activity | 5 | 7 |
GO:0016740 | transferase activity | 2 | 7 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 7 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 4 | 7 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043169 | cation binding | 3 | 7 |
GO:0046872 | metal ion binding | 4 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.476 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.368 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.443 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.533 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.585 |
CLV_PCSK_PC1ET2_1 | 78 | 80 | PF00082 | 0.531 |
CLV_PCSK_PC1ET2_1 | 83 | 85 | PF00082 | 0.585 |
CLV_PCSK_PC7_1 | 79 | 85 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.403 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.419 |
DOC_CYCLIN_RxL_1 | 171 | 184 | PF00134 | 0.470 |
DOC_CYCLIN_RxL_1 | 56 | 70 | PF00134 | 0.422 |
DOC_MAPK_gen_1 | 217 | 224 | PF00069 | 0.423 |
DOC_MAPK_gen_1 | 78 | 88 | PF00069 | 0.379 |
DOC_MAPK_MEF2A_6 | 217 | 224 | PF00069 | 0.569 |
DOC_PP2B_LxvP_1 | 97 | 100 | PF13499 | 0.435 |
DOC_PP4_FxxP_1 | 237 | 240 | PF00568 | 0.416 |
DOC_PP4_FxxP_1 | 264 | 267 | PF00568 | 0.415 |
DOC_USP7_MATH_1 | 35 | 39 | PF00917 | 0.497 |
DOC_USP7_MATH_1 | 7 | 11 | PF00917 | 0.351 |
DOC_WW_Pin1_4 | 12 | 17 | PF00397 | 0.444 |
DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.421 |
DOC_WW_Pin1_4 | 263 | 268 | PF00397 | 0.429 |
LIG_14-3-3_CanoR_1 | 219 | 225 | PF00244 | 0.409 |
LIG_14-3-3_CanoR_1 | 45 | 51 | PF00244 | 0.469 |
LIG_14-3-3_CanoR_1 | 87 | 97 | PF00244 | 0.518 |
LIG_BRCT_BRCA1_1 | 136 | 140 | PF00533 | 0.516 |
LIG_FHA_2 | 167 | 173 | PF00498 | 0.566 |
LIG_LIR_Apic_2 | 211 | 216 | PF02991 | 0.483 |
LIG_LIR_Apic_2 | 235 | 240 | PF02991 | 0.412 |
LIG_LIR_Apic_2 | 261 | 267 | PF02991 | 0.419 |
LIG_LIR_Apic_2 | 90 | 96 | PF02991 | 0.412 |
LIG_LIR_Gen_1 | 162 | 170 | PF02991 | 0.503 |
LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.487 |
LIG_PAM2_1 | 159 | 171 | PF00658 | 0.483 |
LIG_Pex14_2 | 164 | 168 | PF04695 | 0.503 |
LIG_SH2_CRK | 213 | 217 | PF00017 | 0.538 |
LIG_SH2_CRK | 93 | 97 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.542 |
LIG_SH3_3 | 237 | 243 | PF00018 | 0.437 |
LIG_SUMO_SIM_anti_2 | 199 | 205 | PF11976 | 0.473 |
LIG_TRAF2_1 | 145 | 148 | PF00917 | 0.519 |
LIG_UBA3_1 | 163 | 171 | PF00899 | 0.367 |
LIG_UBA3_1 | 220 | 229 | PF00899 | 0.409 |
MOD_CK1_1 | 202 | 208 | PF00069 | 0.375 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.327 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.376 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.321 |
MOD_CK2_1 | 166 | 172 | PF00069 | 0.439 |
MOD_CK2_1 | 18 | 24 | PF00069 | 0.439 |
MOD_CK2_1 | 202 | 208 | PF00069 | 0.228 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.439 |
MOD_GlcNHglycan | 247 | 250 | PF01048 | 0.273 |
MOD_GlcNHglycan | 37 | 40 | PF01048 | 0.359 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.525 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.406 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.417 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.340 |
MOD_GSK3_1 | 35 | 42 | PF00069 | 0.516 |
MOD_N-GLC_1 | 104 | 109 | PF02516 | 0.374 |
MOD_N-GLC_1 | 199 | 204 | PF02516 | 0.369 |
MOD_N-GLC_1 | 7 | 12 | PF02516 | 0.346 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.439 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.423 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.308 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.438 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.391 |
MOD_NEK2_2 | 192 | 197 | PF00069 | 0.323 |
MOD_NEK2_2 | 232 | 237 | PF00069 | 0.403 |
MOD_PK_1 | 28 | 34 | PF00069 | 0.478 |
MOD_PKA_2 | 39 | 45 | PF00069 | 0.515 |
MOD_Plk_1 | 104 | 110 | PF00069 | 0.376 |
MOD_Plk_1 | 199 | 205 | PF00069 | 0.352 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.432 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.354 |
MOD_Plk_4 | 159 | 165 | PF00069 | 0.360 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.323 |
MOD_Plk_4 | 208 | 214 | PF00069 | 0.259 |
MOD_ProDKin_1 | 12 | 18 | PF00069 | 0.448 |
MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.236 |
MOD_ProDKin_1 | 263 | 269 | PF00069 | 0.434 |
MOD_SUMO_for_1 | 196 | 199 | PF00179 | 0.347 |
MOD_SUMO_rev_2 | 48 | 57 | PF00179 | 0.531 |
TRG_DiLeu_BaLyEn_6 | 55 | 60 | PF01217 | 0.382 |
TRG_DiLeu_BaLyEn_6 | 84 | 89 | PF01217 | 0.410 |
TRG_ER_diArg_1 | 32 | 34 | PF00400 | 0.426 |
TRG_ER_diArg_1 | 79 | 81 | PF00400 | 0.368 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I553 | Leptomonas seymouri | 39% | 100% |
A0A3S7WW00 | Leishmania donovani | 89% | 100% |
A4HYS5 | Leishmania infantum | 90% | 100% |
E9AID4 | Leishmania braziliensis | 63% | 100% |
E9AUM1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |